Abstract-Electrophysiological studies using reserpine-treated cats were carried out to elucidate the effects of L-threo-3,4-dihydroxyphenylserine (L-threo-DOPS) on the noradrenergic pathway from the locus coeruleus (LC) to the caudate nucleus (CN) neurons, which were activated by iontophoretically applied bromocriptine, a dopamine D-2 receptor agonist.
Abstract-Electrophysiological studies using reserpine-treated cats were carried out to elucidate the effects of L-threo-3,4-dihydroxyphenylserine (L-threo-DOPS) on the noradrenergic pathway from the locus coeruleus (LC) to the caudate nucleus (CN) neurons, which were activated by iontophoretically applied bromocriptine, a dopamine D-2 receptor agonist.
In the CN neurons, glutamate-induced firing was inhibited by iontophoretic application of noradrenaline, but not by repetitive stimu lation of the LC or iontophoretically applied L-threo-DOPS. After intraventricular administration of L-threo-DOPS, however, LC stimulation inhibited the glutamate induced firing. These results suggest that L-noradrenaline that was produced from the conversion of L-threo-DOPS inhibited the CN neurons which possess dopamine D-2 receptors.
It is well-documented that L-threo-3,4 dihydroxyphenylserine (L-threo-DOPS) is directly converted into L-noradrenaline by L aromatic amino acid decarboxylase in the brain and kidney (1, 2). Systemic adminis tration of L-threo-DOPS to experimental animals, in which monoamines such as noradrenaline were depleted by reserpine or tetrabenazine, is known to increase the noradrenaline level in the brain (3, 4). Our previous studies have also demonstrated that noradrenaline formed from L-threo-DOPS in the locus coeruleus (LC) neurons inhibits the transmission of the spinal trigeminal nucleus neurons (5).
Narabayashi et a!. (6) reported that L threo-DOPS was effective in treating some symptoms of parkinsonism such as akinesia and freezing. Since degeneration of the noradrenaline-containing neurons in the LC concomitantly with degeneration of dopa minergic neurons in the substantia nigra was observed in patients with parkinsonism (7, 8) , the effects of L-threo-DOPS are considered to be due to supplemental noradrenaline in the brain. Previously, we reported that about one third of the caudate nucleus (CN) neurons activated by stimulation of the pars compacta of the substantia nigra were inhibited by noradrenaline derived from the LC (9). In the CN neurons, the spike elicited by nigral stimulation appears to be induced by dopa mine, which acts on postsynaptic dopamine D-2 receptors, since the spike was blocked by iontophoretically applied domperidone, a dopamine D-2 antagoist, and firing of the neu rons was increased by iontophoretic applica tion of D-2 agonists such as bromocriptine and quinpirole (10) (11) (12) (13) . Thus, we preformed an electrophysiological study to examine whether or not noradrenaline converted from L-threo-DOPS affects the CN neurons ac tivated by a dopamine D-2 agonist.
Materials and Methods
Fourteen adult cats weighing 2.6-4.2 kg were given 1 mg/kg, i.m., of reserpine (Daiichi Seiyaku) 24 hr before the experiments. Surgical procedures such as cannulation into the trachea and femoral vein were carried out under ether anesthesia. The head of the animal was fixed in a stereotaxic instrument. After the operation, the ether anesthesia was re placed with a-chloralose (30 mg/kg, i.v.), and the animal was immobilized with gal lamine triethiodide (5 mg/kg/hr, i.v.) under artificial respiration. All wound edges and pressure points were locally anesthetized with 8% lidocaine spray throughout the ex periments. Supplemental doses of a-chlo ralose (each 10-15 mg/kg, i.v.) were added as required. Body temperature was main tained at 36.5-37.5 °C with a heating pad. The ECG (II lead) was continuously moni tored during the experiments, and under these conditions, the animal was considered to be well-anesthetized since there were no obvious changes in the ECG when the stimulus was applied to the LC.
Single neuron activities in the head of the left CN (A: 16.0-18.0, L: 3.0-6.0, H: 3.0-8.0) (14) were recorded extracellularly using a glass-insulated silver wire microelectrode (an electrical resistance of approx. 1 MQ) at tached along a seven-barreled micropipette (Fig. 1) . Each pipette was filled with 4 mM bromocriptine mesylate (Sandoz, dissolved in 0.3% tartrate, pH 4.0), 1 M monosodium L-glutamate (Sigma, pH 7.5), 0.5 M (±) noradrenaline bitartrate (Sigma, pH 4.5), 10 mM L-threo-DOPS (Sumitomo Seiyaku; dissolved in 1 N HCI, pH adjusted to 5.0 by adding 0.2 N NaOH) and 3 M NaCI. These chemicals were iontophoretically applied to the immediate vicinity of the target neuron being recorded using a microiontophoresis programmer (WP-I, Model 160). A retaining current of 10-20 nA was continuously ejected to prevent the spontaneous leakage of the drugs from the pipette. L-threo-DOPS (0.1 ml of 0.2 mg) was applied into the right lateral ventricle (A: 14.0, L: 3.0, H: 7.5) (14) through a needle previously fixed on the skull. Spontaneous and glutamate-induced firings were continuously recorded on an ink-writing recorder (Nihon Kohden, RJG 4022) through a spike counter (Dia Medical System, DSE-325P). Repetitive stimuli (0.2 msec, 0.1 and 0.5 mA, 20 Hz) were applied to the LC (P: 2.0, L: 2.0, H: -2.0) (15) ipsila teral to the recording site for 20 sec. The data were analyzed by Student's t-test. After the end of the experiments, the recording and stimulating sites were marked by passing a direct current of 20-100 aA for 10-20 sec and then checked by staining with cresyl violet. Further details of the experimental pro cedures have been described elsewhere (16) . Results Most CN neurons had a low spontaneous firing rate of less than 1 /sec. lontophretic ap plication of bromocriptine at doses of 100 200 nA increased the firing rate in 22 of 45 CN neurons in 14 reserpine-treated cats (Fig.  2) , as reported previously in the untreated cats (12) . The increase in firing rate was seen 10-60 sec after the onset of the application, and it lasted for 10-120 sec after the cessation of the application. Numbers under the bars and dotted lines show the applied current in nA and stimulus intensity in mA to the LC, respectively.
In the 22 CN neurons activated by bro mocriptine, the effects of iontophoretically applied noradrenaline and L-threo-DOPS on glutamate-induced firing were examined. lontophoretic application of glutamate (20 25 nA) elicited a reproducible firing in all neurons tested with firing rates ranging from 10 to 30/sec. When noradrenaline (25-100 nA) was applied for 60 sec, a decrease in the glutamate-induced firing was observed in 12 of the 22 neurons. In contrast, iontophoreti cally applied L-threo-DOPS up to 200 nA did not affect the glutamate-induced firing in any neuron. The glutamate-induced firing was not altered by repetitive stimulation of the LC (Fig. 2) .
In the next series of experiments, the ef fects of LC stimulation after intraventricular administration of L-threo-DOPS (0.2 mg) were examined in 7 CN neurons activated by iontophoretically applied bromocriptine and inhibited by noradrenaline. When repetitive stimuli (0.1 and 0.5 mA) were applied to the LC for 20 sec, none of the 7 neurons ex hibited over 50% inhibition of the maximum firing induced by glutamate before intraven tricular administration of L-threo-DOPS (Table 1) . After subsequent administration of L-threo-DOPS into the lateral ventricle, however, the glutamate-induced firing was suppressed by LC stimulation in all neurons tested. A slight inhibition was seen 15 min after the administration of L-threo-DOPS, and a significant reduction of the firing rate was observed 30-45 min after application of L-threo-DOPS when the stimuli were applied to the LC (Fig. 2 and Table 1 ). Table 1 . Effects of iontophoretically applied noradrenaline (NA) and L-threo-DOPS and locus coeru leus stimulation (LC-stim) on glutamate-induced firing of the caudate nucleus neurons in reserpine treated cats Discussion About 50% of the examined CN neurons were activated by bromocriptine, and these neurons were considered to receive ex citatory input from the substantia nigra via dopamine D-2 receptors, as already reported (11) (12) (13) . Furthermore, half of the neurons activated by bromocriptine were inhibited by iontophoretic application of noradrenaline in reserpine-treated animals. These results are in line with the previous findings (9) that spike generation of the CN neurons upon nigral stimulation was inhibited by ion tophoretically applied noradrenaline as well as by stimuli applied to the LC preceding the test stimulation to the substantia nigra. There fore, these neurons presumably possess both dopamine D-2 and adrenergic receptors. When the effects of LC stimulation on these CN neurons were examined in reserpine treated animals, no inhibition of the gluta mate-induced firing was observed. The lack of effects of LC stimulation was probably due to the depletion of noradrenaline from the noradrenergic nerve terminals, since 1 mg/kg (i.m.) of reserpine was sufficient to markedly reduce the amine (17).
However, the inhibition by the LC stimu lation was seen in all neurons tested after intraventricular administration of L-threo DOPS. Systemic administration of L-threo DOPS to the animals treated with reserpine reportedly increased the noradrenaline con tent in the brain (4). In addition, Q-adrenergic receptor-mediated inhibition of the spinal trigeminal nucleus neurons by LC condi tioning stimulation was observed following intraventricular application of L-threo-DOPS to the reserpine-treated animals in a pre vious study (5), which was performed under experimental conditions similar to those in the present study. Therefore, the inhibition induced by LC stimulation described here is considered to be due to noradrenaline con verted from L-threo-DOPS in the nor adrenergic neurons derived from the LC. The possibility that L-threo-DOPS itself acted on the CN neurons can be excluded, since the amino acid iontophoretically applied to the target neuron had no effects in both the present and previous studies (5).
Although the uptake of noradrenaline into the synaptic vesicles is inhibited in the animals treated with reserpine, some nor adrenaline formed from L-threo-DOPS in the cytoplasm is still taken up into the vesicles since the degree of inhibition of the uptake is dependent upon the doses of reserpine, as described previously (5, 18). In conclusion, it is suggested that L-threo-DOPS acts on some of the CN neurons after conversion to noradrenaline in the noradrenergic neurons originating in the LC. 
